National Institute of Diabetes and Digestive and Kidney Diseases
Schedules
TAFS: 075-0884 /X - National Institute of Diabetes and Digestive and Kidney Diseases
| Line # | Split | Description | Iteration 2 Previously Approved Amount | Iteration 3 Current OMB Action Amount | Footnotes |
|---|---|---|---|---|---|
| 1000 | MA | Mandatory Actual - Unob Bal: Brought forward, October 1 | $397,627,687 | $397,627,687 | |
| 1021 | Unob Bal: Recov of prior year unpaid obligations | $117,300 | +$5,515 $122,815 | ||
| 1000 | ME | Mandatory Expected - Unob Bal: Brought forward, October 1 | $0 | Line removed— | |
| 1033 | Unob Bal: Recov of prior year paid obligations | $5,184 | -$1,405 $3,779 | ||
| 1061 | Unob Bal: Antic recov of prior year unpd/pd obl | $2,377,516 | -$4,110 $2,373,406 | ||
| 1200 | BA: Mand: Appropriation | $39,261,745 | +$79,832,215 $119,093,960 | See footnotes below | |
| Footnotes for line 1200 (Previous): | B1: Pursuant to P.L. 118-158, $39,261,745 was appropriated for Type 1 Diabetes, for the period beginning on January 1, 2025, and ending on March 31, 2025, to remain available until expended. | ||||
| Footnotes for line 1200 (Current): | B1: Pursuant to P.L. 118-158 and P.L. 119-4, $119,093,960 was appropriated for type 1 Diabetes with funds to remain available until expended. Of this amount, $39,261,745 is pursuant to P.L. 118-158 and covers the period beginning on January 1, 2025 and ending on March 31, 2025. Of this amount, $79,832,215 is pursuant to P.L. 119-4 and covers the period beginning on April 1, 2025 and ending on September 30, 2025. | ||||
| 1800 | BA: Mand: Spending auth: Collected | $3,995 | +$18,265 $22,260 | ||
| 1840 | BA: Mand: Spending auth:Antic colls, reimbs, other | $396,005 | -$18,265 $377,740 | ||
| 1920 | Total budgetary resources avail (disc. and mand.) | $439,789,432 | +$79,832,215 $519,621,647 | See footnotes below | |
| Footnotes for line 1920 (Previous): | B2: Pursuant to section 120.21 of OMB Circular A-11, one or more lines in the Budgetary Resources section may be rounded up. As a result, those rounded lines will not match the actuals reported on the SF 133. Agency will ensure that its funds control system will only allot actuals. | ||||
| Footnotes for line 1920 (Current): | B2: Pursuant to section 120.21 of OMB Circular A-11, one or more lines in the Budgetary Resources section may be rounded up. As a result, those rounded lines will not match the actuals reported on the SF 133. Agency will ensure that its funds control system will only allot actuals. | ||||
| 6001 | Category A -- 1st quarter | $1,400,000 | $1,400,000 | ||
| 6002 | Category A -- 2nd quarter | -$127,429 | -$127,429 | ||
| 6011 | Type 1 Diabetes | $438,516,861 | +$79,832,215 $518,349,076 | ||
| 6190 | Total budgetary resources available | $439,789,432 | +$79,832,215 $519,621,647 | See footnotes below | |
| Footnotes for line 6190 (Previous): | A1: The total amount apportioned may be increased for additional spending authority from offsetting collections and reimbursables received and for recoveries of prior year obligations by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available. The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. [Rationale: Footnote signifies that this TAFS has received or may receive an automatic apportionment.] | ||||
| Footnotes for line 6190 (Current): | A1: The total amount apportioned may be increased for additional spending authority from offsetting collections and reimbursables received and for recoveries of prior year obligations by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available. The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. | ||||
Footnotes
Footnotes provide further information about, or establish further legal requirements related to the use of, the funds in a given line or set of lines in an apportionment. If footnotes appear on lines 1920 or 6190, they apply to all the lines in the 1xxx and 6xxx sections, respectively. The following are all the footnotes associated with this file.
| Number | Text |
|---|---|
| A1 | The total amount apportioned may be increased for additional spending authority from offsetting collections and reimbursables received and for recoveries of prior year obligations by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available. The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. |
| B1 | Pursuant to P.L. 118-158 and P.L. 119-4, $119,093,960 was appropriated for type 1 Diabetes with funds to remain available until expended. Of this amount, $39,261,745 is pursuant to P.L. 118-158 and covers the period beginning on January 1, 2025 and ending on March 31, 2025. Of this amount, $79,832,215 is pursuant to P.L. 119-4 and covers the period beginning on April 1, 2025 and ending on September 30, 2025. |
| B2 | Pursuant to section 120.21 of OMB Circular A-11, one or more lines in the Budgetary Resources section may be rounded up. As a result, those rounded lines will not match the actuals reported on the SF 133. Agency will ensure that its funds control system will only allot actuals. |
The following are all of the footnotes associated with the previous iteration of this file. Note that previous iterations of accounts in this file may come from multiple previous files.
| Number | Text |
|---|---|
| A1 | The total amount apportioned may be increased for additional spending authority from offsetting collections and reimbursables received and for recoveries of prior year obligations by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available. The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. [Rationale: Footnote signifies that this TAFS has received or may receive an automatic apportionment.] |
| B1 | Pursuant to P.L. 118-158, $39,261,745 was appropriated for Type 1 Diabetes, for the period beginning on January 1, 2025, and ending on March 31, 2025, to remain available until expended. |
| B2 | Pursuant to section 120.21 of OMB Circular A-11, one or more lines in the Budgetary Resources section may be rounded up. As a result, those rounded lines will not match the actuals reported on the SF 133. Agency will ensure that its funds control system will only allot actuals. |
Notes about this page
- † Links to public laws are automatically generated and are not guaranteed to be accurate.